BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21727276)

  • 1. Effects of prophylactic indomethacin in extremely low-birth-weight infants with and without adequate exposure to antenatal corticosteroids.
    Schmidt B; Seshia M; Shankaran S; Mildenhall L; Tyson J; Lui K; Fok T; Roberts R;
    Arch Pediatr Adolesc Med; 2011 Jul; 165(7):642-6. PubMed ID: 21727276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    Schmidt B; Asztalos EV; Roberts RS; Robertson CM; Sauve RS; Whitfield MF;
    JAMA; 2003 Mar; 289(9):1124-9. PubMed ID: 12622582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.
    Schmidt B; Davis P; Moddemann D; Ohlsson A; Roberts RS; Saigal S; Solimano A; Vincer M; Wright LL;
    N Engl J Med; 2001 Jun; 344(26):1966-72. PubMed ID: 11430325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms.
    Alfaleh K; Smyth JA; Roberts RS; Solimano A; Asztalos EV; Schmidt B;
    Pediatrics; 2008 Feb; 121(2):e233-8. PubMed ID: 18245398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Prophylactic Indomethacin in Extremely Low Birth Weight Infants Based on the Predicted Risk of Severe Intraventricular Hemorrhage.
    Foglia EE; Roberts RS; Stoller JZ; Davis PG; Haslam R; Schmidt B;
    Neonatology; 2018; 113(2):183-186. PubMed ID: 29258076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG
    Cochrane Database Syst Rev; 2002; (3):CD000174. PubMed ID: 12137607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
    Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID; Higgins RD;
    JAMA; 2011 Dec; 306(21):2348-58. PubMed ID: 22147379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.
    Couser RJ; Ferrara TB; Wright GB; Cabalka AK; Schilling CG; Hoekstra RE; Payne NR
    J Pediatr; 1996 May; 128(5 Pt 1):631-7. PubMed ID: 8627434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
    Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
    Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male/female differences in indomethacin effects in preterm infants.
    Ohlsson A; Roberts RS; Schmidt B; Davis P; Moddeman D; Saigal S; Solimano A; Vincer M; Wright L;
    J Pediatr; 2005 Dec; 147(6):860-2. PubMed ID: 16356449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.
    Fowlie PW
    Cochrane Database Syst Rev; 2000; (2):CD000174. PubMed ID: 10796168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Dysart KC; Gantz MG; Carper B; Higgins RD; Keszler M; Laughon MM; Poindexter BB; Stoll BJ; Walsh MC; Schmidt B;
    J Pediatr; 2017 Jul; 186():34-40.e2. PubMed ID: 28258737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating extremely low birthweight infants with prophylactic indomethacin. Evidence for short term benefits only.
    McGuire W; Fowlie PW
    BMJ; 2002 Jan; 324(7329):60-1. PubMed ID: 11786435
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age.
    Wadhawan R; Oh W; Vohr BR; Saha S; Das A; Bell EF; Laptook A; Shankaran S; Stoll BJ; Walsh MC; Higgins R
    Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F127-32. PubMed ID: 22684157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.